news Nimbus Therapeutics enters into strategic partnership with Charles River Laboratories to advance new therapeutic programsBy Charles River Laboratories
news Discovery of ‘mini-brains’ could change understanding of pain medicationBy Niamh Marriott (Drug Target Review)
news Genomic data portal Repositive receives £2.5 million in fundingBy Niamh Marriott (Drug Target Review)
news Elimination of specific neurons outside the brain by new technique triggers obesityBy Niamh Marriott (Drug Target Review)
news IntelliCyt launches novel assay system to accelerate cell line developmentBy IntelliCyt Corporation
news World-leading imaging centre of excellence opened in GlasgowBy Niamh Marriott (Drug Target Review)
news Nexeon acquires license to 86 patents related to Internet of ThingsBy Niamh Marriott (Drug Target Review)
news MRI use may “change the equation” for prostate cancer screeningBy Niamh Marriott (Drug Target Review)
news AI to help create automated virtual GPs to advise patients onlineBy Niamh Marriott (Drug Target Review)
news Researchers to develop ‘wearable’ robotic tools for surgeryBy Niamh Marriott (Drug Target Review)
Follow: